Kala Bio (KALA) Cash from Investing Activities (2016 - 2026)

Kala Bio has reported Cash from Investing Activities for 11 years, with the latest figure at -$7.0 million in Q1 2026.

• Quarterly Cash from Investing Activities changed N/A year-over-year to -$7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (changed N/A YoY) and the FY2025 annual result came in at -$15000.0, up 92.79% from the prior year.
• Cash from Investing Activities slipped to -$7.0 million in Q1 2026 per KALA's latest filing, from $1000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $64.9 million in Q3 2022 and troughed at -$10.0 million in Q2 2023.
• A 5-year average of $3.9 million and a median of -$24500.0 in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 1274.94% in 2022, then slumped 885.71% in 2024.
• Over 5 years, Cash from Investing Activities stood at $51000.0 in 2022, then plunged by 113.73% to -$7000.0 in 2023, then plunged by 885.71% to -$69000.0 in 2024, then jumped by 101.45% to $1000.0 in 2025, then tumbled by 700100.0% to -$7.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$7.0 million, $1000.0, and -$69000.0 for Q1 2026, Q3 2025, and Q4 2024 respectively.